Contains fulltext : 99304.pdf (publisher's version ) (Closed access)Effects of the cannabinoid antagonist rimonabant on the EEG were investigated in healthy, non-epileptic rats. The drug was administered orally at 30 mg/kg/day for 3 weeks. The EEG was recorded continuously. In 3 out of 13 rats, limbic convulsive seizures, which were not related to the time of drug administration, were observed after 5-8 days. We hypothesize that an accumulation of micro-injuries in the brain is responsible for these "spontaneous" seizures.4 p
Dyskinesias and seizures are both medically refractory disorders for which cannabinoid-based treatme...
Contains fulltext : 90547.pdf (publisher's version ) (Closed access)Purpose: Genet...
Copyright © 2011 Anushka V. Goonawardena et al. This is an open access article distributed under the...
Effects of the cannabinoid antagonist rimonabant on the EEG were investigated in healthy, non-epilep...
Contains fulltext : 166569.pdf (publisher's version ) (Open Access)Cannabinoid CB1...
Cannabinoid CB1 antagonists have been investigated for possible treatment of e.g. obesity-related di...
Contains fulltext : 162086.pdf (publisher's version ) (Open Access)19th biennial I...
Item does not contain fulltextBACKGROUND: Modulation of the endocannabinoid (eCB) transmission is a ...
Item does not contain fulltextPurpose: This study was performed to investigate whether stimulation o...
Item does not contain fulltextAn acute brain insult can cause a spectrum of primary and secondary pa...
Item does not contain fulltextEndocannabinoid system and its CB1 receptors are suggested to provide ...
Contains fulltext : 29053.pdf (publisher's version ) (Open Access)Effects of the a...
Post-traumatic epilepsy (PTE) is one of the most common complications resulting from brain injury, h...
Contains fulltext : 29056.pdf (publisher's version ) (Open Access)The mechanism of...
Contains fulltext : 56060.pdf (publisher's version ) (Closed access)The effects of...
Dyskinesias and seizures are both medically refractory disorders for which cannabinoid-based treatme...
Contains fulltext : 90547.pdf (publisher's version ) (Closed access)Purpose: Genet...
Copyright © 2011 Anushka V. Goonawardena et al. This is an open access article distributed under the...
Effects of the cannabinoid antagonist rimonabant on the EEG were investigated in healthy, non-epilep...
Contains fulltext : 166569.pdf (publisher's version ) (Open Access)Cannabinoid CB1...
Cannabinoid CB1 antagonists have been investigated for possible treatment of e.g. obesity-related di...
Contains fulltext : 162086.pdf (publisher's version ) (Open Access)19th biennial I...
Item does not contain fulltextBACKGROUND: Modulation of the endocannabinoid (eCB) transmission is a ...
Item does not contain fulltextPurpose: This study was performed to investigate whether stimulation o...
Item does not contain fulltextAn acute brain insult can cause a spectrum of primary and secondary pa...
Item does not contain fulltextEndocannabinoid system and its CB1 receptors are suggested to provide ...
Contains fulltext : 29053.pdf (publisher's version ) (Open Access)Effects of the a...
Post-traumatic epilepsy (PTE) is one of the most common complications resulting from brain injury, h...
Contains fulltext : 29056.pdf (publisher's version ) (Open Access)The mechanism of...
Contains fulltext : 56060.pdf (publisher's version ) (Closed access)The effects of...
Dyskinesias and seizures are both medically refractory disorders for which cannabinoid-based treatme...
Contains fulltext : 90547.pdf (publisher's version ) (Closed access)Purpose: Genet...
Copyright © 2011 Anushka V. Goonawardena et al. This is an open access article distributed under the...